Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · IEX Real-Time Price · USD
4.650
-0.020 (-0.43%)
At close: May 31, 2024, 4:00 PM
4.770
+0.120 (2.58%)
After-hours: May 31, 2024, 4:08 PM EDT
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $194.62 million as of May 31, 2024. Its market cap has decreased by -1.66% in one year.
Market Cap
194.62M
Enterprise Value
186.19M
1-Year Change
-1.66%
Ranking
Category
Stock Price
$4.65
Market Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $194.62M, an increase of 41.23%. That is a compound annual growth rate of 3.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 194.60M | -0.46% |
May 30, 2024 | 195.50M | 1.66% |
May 29, 2024 | 192.30M | 0.73% |
May 28, 2024 | 190.90M | -2.10% |
May 24, 2024 | 195.00M | 3.78% |
May 23, 2024 | 187.90M | -3.04% |
May 22, 2024 | 193.80M | 0.21% |
May 21, 2024 | 193.40M | -1.48% |
May 20, 2024 | 196.30M | -0.86% |
May 17, 2024 | 198.00M | -0.60% |
May 16, 2024 | 199.20M | -1.24% |
May 15, 2024 | 201.70M | 0.40% |
May 14, 2024 | 200.90M | -1.86% |
May 13, 2024 | 204.70M | 1.49% |
May 10, 2024 | 201.70M | -4.18% |
May 9, 2024 | 210.50M | -6.07% |
May 8, 2024 | 224.10M | -0.27% |
May 7, 2024 | 224.70M | 0.36% |
May 6, 2024 | 223.90M | 7.18% |
May 3, 2024 | 208.90M | 1.26% |
May 2, 2024 | 206.30M | 3.25% |
May 1, 2024 | 199.80M | 0.45% |
Apr 30, 2024 | 198.90M | 0.66% |
Apr 29, 2024 | 197.60M | 0.66% |
Apr 26, 2024 | 196.30M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
NeuroPace | 198.79M |
Delcath Systems | 195.89M |
Inogen | 195.69M |
Scilex Holding Company | 195.69M |
Omeros | 194.69M |
TriSalus Life Sciences | 194.46M |
Compugen | 194.28M |
Compass Therapeutics | 194.00M |